VIVIMEDLAB logo

Vivimed Labs Limited Stock Price

NSEI:VIVIMEDLAB Community·₹410.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VIVIMEDLAB Share Price Performance

₹0
0.00 (0.00%)
₹0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

VIVIMEDLAB Community Narratives

There are no narratives available yet.

Snowflake Analysis

Good value with weak fundamentals.

4 Risks
1 Reward

Vivimed Labs Limited Key Details

₹1.7b

Revenue

₹2.6b

Cost of Revenue

-₹886.4m

Gross Profit

₹2.3b

Other Expenses

-₹3.2b

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
-38.82
-51.14%
-185.70%
960.3%
View Full Analysis

About VIVIMEDLAB

Founded
1988
Employees
607
CEO
Santosh Varalwar
WebsiteView website
www.vivimedlabs.com

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

Recent VIVIMEDLAB News & Updates

Recent updates

No updates